HIGHLIGHTS
- who: Saleha Alqarni and Mashael Alsebai from the University of Guelph, Canada have published the research: Could VGF and/or its derived peptide act as biomarkers for the diagnosis of neurodegenerative diseases: A systematic review, in the Journal: (JOURNAL)
- what: There is no intervention because this systematic review aimed to investigate the level of VGF in adults with neurodegenerative diseases compared to adults without neurodegenerative diseases. Four studies were conducted on people with AD , two studies were conducted on people with PD , and three studies were conducted on people with ALS . Was the research question . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.